YOU WILL RECEIVE A CALL THAT MAY QUALIFY YOUR CHILD FOR THIS STUDY
CALL 855-971-2634 OR HAVE US CALL YOU:
YOU WILL RECEIVE A CALL THAT MAY QUALIFY YOUR CHILD FOR THIS STUDY

The Study

Tourette syndrome is a neurodevelopmental disorder characterized by multiple motor and phonic tics that frequently co-occurs with a variety of behavioral and psychiatric problems.

This up to 18-week study has been approved by the US Food and Drug Administration to evaluate the efficacy and safety of investigational medication for the reduction of motor and phonic tics associated with Tourette syndrome in children and adolescents 6 through 16 years of age. Studies have suggested that up to 7% of school children fulfill the diagnostic criteria for Tourette syndrome.

A diagnosis of Tourette syndrome requires having at least two “motor tics” and at least one “vocal / phonic tic” over the course of a year.